References
P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, J.I. Gordon, An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122), 1027–1031 (2006)
V. Tremaroli, F. Bäckhed, Functional interactions between the gut microbiota and host metabolism. Nature 489(7415), 242–249 (2012)
E. Angelakis, V. Merhej, D. Raoult, Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect. Dis. 13(10), 889–899 (2013)
L. Trasande, J. Blustein, M. Liu, E. Corwin, L.M. Cox, M.J. Blaser, Infant antibiotic exposures and early-life body mass. Int. J. Obes. (Lond.) 37(1), 16–23 (2013)
L.W. Riley, E. Raphael, E. Faerstein, Obesity in the United States - dysbiosis from exposure to low-dose antibiotics? Front Public Health. 1, 69 (2013)
R. Murphy, A.W. Stewart, I. Braithwaite, R. Beasley, R.J. Hancox, E.A. Mitchell, The ISAAC Phase Three Study Group, Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int. J. Obes. (Lond.) 38(8), 1115–1119 (2014)
F. Thuny, H. Richet, J.P. Casalta, E. Angelakis, G. Habib, D. Raoult, Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 5(2), e9074 (2010)
A. Vrieze, C. Out, S. Fuentes et al., Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 60(4), 824–831 (2014)
M. Million, F. Thuny, E. Angelakis et al., Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment. Nutr. Diabetes. 3, e87 (2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bifulco, M. Antibiotics exposure in obesity: an update of a complex relationship. Endocrine 48, 12–13 (2015). https://doi.org/10.1007/s12020-014-0421-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0421-9